株式会社ＰＲＩＳＭ ＢｉｏＬａｂ
A biotech creating novel drugs by targeting previously "undruggable" protein interactions.
206A | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 藤沢市村岡東二丁目２６番１号
- Website:
- https://prismbiolab.com/ja/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
PRISM BioLab is a biotechnology company dedicated to creating novel small molecule drugs for diseases that currently lack effective treatments. The company's core is its proprietary PepMetics® drug discovery platform, which enables the targeting of previously "undruggable" proteins. This technology utilizes unique small molecule scaffolds that mimic peptide structures (α-helices and β-turns) to control protein-protein interactions (PPIs), a key cause of many diseases. By making these challenging targets accessible, PRISM BioLab aims to pioneer new therapies and collaborates with pharmaceutical companies to advance its drug discovery programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-07-17 09:30 |
Major Shareholding Notification
臨時報告書
|
Japanese | 21.0 KB | ||
| 2025-05-14 09:31 |
Registration Form
確認書
|
Japanese | 8.7 KB | ||
| 2025-05-14 09:30 |
Interim Report
半期報告書－第14期(2024/10/01－2025/09/30)
|
Japanese | 224.7 KB | ||
| 2024-12-27 07:34 |
Regulatory News Service
内部統制報告書－第13期(2023/10/01－2024/09/30)
|
Japanese | 22.2 KB | ||
| 2024-12-27 07:33 |
Registration Form
確認書
|
Japanese | 8.7 KB | ||
| 2024-12-27 07:32 |
Annual Report
有価証券報告書－第13期(2023/10/01－2024/09/30)
|
Japanese | 3.1 MB | ||
| 2024-12-27 07:31 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 22.1 KB | ||
| 2024-11-14 07:32 |
Regulatory News Service
臨時報告書
|
Japanese | 20.8 KB | ||
| 2024-10-16 10:12 |
Major Shareholding Notification
臨時報告書
|
Japanese | 20.7 KB | ||
| 2024-09-10 09:09 |
Regulatory News Service
臨時報告書
|
Japanese | 19.9 KB | ||
| 2024-06-24 08:00 |
Prospectus
訂正有価証券届出書（新規公開時）
|
Japanese | 2.2 MB | ||
| 2024-06-14 08:00 |
Registration Form
訂正有価証券届出書（新規公開時）
|
Japanese | 2.3 MB | ||
| 2024-05-27 08:00 |
Registration Form
有価証券届出書（新規公開時）
|
Japanese | 4.3 MB |
Automate Your Workflow. Get a real-time feed of all 株式会社ＰＲＩＳＭ ＢｉｏＬａｂ filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for 株式会社ＰＲＩＳＭ ＢｉｏＬａｂ via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
